Format

Send to

Choose Destination
Gene Ther. 2003 Nov;10(24):1999-2004.

Gene therapy progress and prospects: gene therapy for severe combined immunodeficiency.

Author information

1
Molecular Immunology Unit, Institute of Child Health, London, UK.

Abstract

Severe combined immunodeficiencies have long been targeted as a group of disorders amenable to gene therapy because of their defined molecular biology and pathophysiology, and the prediction that corrected cells would have profound growth and survival advantage. Recently, several clinical studies have shown that conventional gene transfer technology can produce major beneficial therapeutic effects in these patients, but, as for all cellular and pharmacological treatment approaches, with a finite potential for toxicity.

PMID:
14566358
DOI:
10.1038/sj.gt.3302150
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center